Finance

Lists
ENTX:NASDAQ
Entera Bio Ltd
US$ ३.३०
+०.७६%
(+०.०२५) 1D
US$ ३.३५
+१.३६% (+०.०४५)
After hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
US$ ३.२५
High
US$ ३.३३
Low
US$ ३.१८
Mkt. cap
५७.५५ करोड
Avg. vol.
४.३९ लाख
Volume
४.६९ लाख
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३९
Beta
१.४८
Shares outstanding
१७.४१ करोड
No. of employees
२७
Open
US$ ३.२५
High
US$ ३.३३
Low
US$ ३.१८
Mkt. cap
५७.५५ करोड
Avg. vol.
४.३९ लाख
Volume
४.६९ लाख
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३९
Beta
१.४८
Shares outstanding
१७.४१ करोड
No. of employees
२७
News stories
From web sources and news partners
Gulf Coast News and Weather
Gulf Coast News and Weather
·
२५ मिनेट पहिले
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
The Motley Fool
The Motley Fool
·
१ घण्टा पहिले
If I Could Tell All S&P 500 Investors Just 1 Thing Right Now, It's This
About Entera Bio Ltd
CEO-
Employees२७
Founded२००९
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current US$ ३.३०
US$ ११.०० (+२३२.८३%)
Average
US$ १०.०० (+२०२.५७%)
Lowest
US$ ९.०० (+१७२.३१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Maintained
US$ ११.००
+२३२.८%
11/09/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
US$ १०.००
+२०२.६%
10/14/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
US$ ९.००
+१७२.३%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ९.००
+१७२.३%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१७.१८ लाख
२२.५१ लाख
३२.०१ लाख
४९.२५ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१३.२४ लाख
१२.८८ लाख
१३.६२ लाख
२३.४० लाख
Operating expense
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
७२.६५ लाख
Total operating expenses
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
७२.६५ लाख
Operating income
-३०.४२ लाख
-३५.३९ लाख
-४५.६३ लाख
-७२.६५ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
-१.५६ करोड
EBT excluding unusual items
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
-१.५६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
-१.५६ करोड
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
२६.०० हजार
३४.०० हजार
-
-
Interest expense
-
-
-२७.४९ लाख
-८३.३२ लाख
Net interest expenses
२६.०० हजार
३४.०० हजार
-२७.४९ लाख
-८३.३२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३०.३५ लाख
-३५.३२ लाख
-४५.५४ लाख
-७२.५६ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू